about
Cognitive neuropsychology of HIV-associated neurocognitive disordersCommon immunologic determinant between human immunodeficiency virus type 1 gp41 and astrocytesNuclear localization signal of HIV-1 as a novel target for therapeutic interventionCerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatmentBlood-brain barrier and retroviral infectionsHIV-associated neuropathogenesis: a systems biology perspective for modeling and therapyGenetic, transcriptomic, and epigenetic studies of HIV-associated neurocognitive disorderCommon transcriptional signatures in brain tissue from patients with HIV-associated neurocognitive disorders, Alzheimer's disease, and Multiple SclerosisHIV Associated Neurocognitive DisordersManagement of cerebral infection.Declining incidence of AIDS dementia complex after introduction of zidovudine treatmentFactors in AIDS dementia complex trial design: results and lessons from the abacavir trialDopamine receptor activation increases HIV entry into primary human macrophagesActivation of glycogen synthase kinase 3 beta (GSK-3beta) by platelet activating factor mediates migration and cell death in cerebellar granule neuronsM- and T-tropic HIVs promote apoptosis in rat neuronsHIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment.Fragile X tremor ataxia syndrome and white matter dementia.Clinical Trials in Neurovirology: Successes, Challenges, and PitfallsThe role of host genetics in the susceptibility for HIV-associated neurocognitive disorders.Functional polymorphisms in dopamine-related genes: effect on neurocognitive functioning in HIV+ adults.Post mortem examinations of HIV infected patients: a nationwide survey.Cerebral white matter: neuroanatomy, clinical neurology, and neurobehavioral correlatesIdentification and cloning of human astrocyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RaSH.Changes in cerebral metabolism are detected prior to perfusion changes in early HIV-CMC: A coregistered (1)H MRS and SPECT study.YKL-40, a marker of simian immunodeficiency virus encephalitis, modulates the biological activity of basic fibroblast growth factor.Early HIV-related neuropsychological impairment: relationship to stage of viral infection.Amyloid and tau cerebrospinal fluid biomarkers in HIV infection.Human immunodeficiency virus infection and diffuse polyneuropathy. Implications for rehabilitation medicine.Proton magnetic resonance spectroscopy reveals neuroprotection by oral minocycline in a nonhuman primate model of accelerated NeuroAIDSNeurologic presentations of AIDS.Neuropsychological abnormalities in AIDS and asymptomatic HIV seropositive patients.Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individualsCombined HIV-CMV encephalitis presenting with brainstem signs.Examination of brains of AIDS cases for human immunodeficiency virus and human cytomegalovirus nucleic acids.Anti-HIV antibodies in the CSF of AIDS patients: a serological and immunoblotting study.Predictors of CNS injury as measured by proton magnetic resonance spectroscopy in the setting of chronic HIV infection and CART.HIV infection and seizures.TRPC channels and their implication in neurological diseasesMethamphetamine abuse, HIV infection, and neurotoxicity.Neurocognitive functioning in HIV-1 infection: effects of cerebrovascular risk factors and age
P2860
Q22252615-DFDBE354-B9A0-415D-A600-377FBF8D40FFQ24648466-52CCFE45-C472-42A3-806A-F36CD440F601Q24654984-69E3F925-B6C4-4CD1-856E-966DF7A169A0Q24814874-44BDF788-9F2D-432F-9F57-54F6DAFD4762Q26830903-164AC06E-C516-4191-AA37-D67B12124783Q26859071-CCF7B52D-2827-4C38-BF38-22215C0490B7Q26865707-25F30744-819C-4CAB-B9B3-B53ACDA9549BQ27007041-CFCED331-F369-45DA-8BA4-B5A8649EA429Q27023968-260F67EB-60CB-451B-ACE9-B5BF6AD59CD0Q27469303-9F1CA560-F6DA-4003-87E3-BBB29412904EQ28341520-0BA0B791-71D1-40B1-87E3-388525589AB8Q28469174-71E923EC-C533-469A-BB1E-2BDC0084788DQ28543414-DE5EC695-D5FB-4139-8F7F-D1E56DE7508AQ28565001-653E65D7-B9AF-49DB-8FA0-83443C515103Q28572213-841CD8F9-F2B6-461E-ACA0-167B072795E7Q30234305-55A11736-2D55-4CB7-AC81-6AD8EA1AADDFQ30249228-6618157D-0115-4274-B52E-7CAC7F0BFBD0Q30250271-5B569E46-B0A9-4F25-96A8-FAD5D9958D2CQ30411844-EEA58A30-9EEF-4A97-A43B-27351AB6D751Q30416710-B3764388-7AAA-4F13-9CDC-ED4B8C06A318Q30421686-87B86E00-3380-4690-8651-7583C1F1760BQ30450267-25F40B6B-B4A1-4877-9AF3-AFF570A83CD9Q31063118-C107E07E-7F48-4156-ABBE-E3E9B4FFBEE9Q31651608-9E098450-C606-4D5C-9432-0FDAE2EE271AQ33343967-D22B8BDA-3A3E-4D96-9BE1-BC71555387BBQ33390496-9BF2770A-89A0-4480-9E5B-C21608682012Q33520347-2E05E74D-A36A-4FD0-93BD-3CA60047FD20Q33559155-55F93491-DD97-4687-9DC9-F586538DA5E4Q33580220-18C78861-97E0-46EC-B642-6AB93E97E58AQ33590337-B8D1F347-450B-46F2-A3A3-168B34E1347BQ33591573-591CC1F2-791A-4B2E-842D-78241F9700ACQ33614467-3BCFCCE9-3494-45C5-B872-19D3545E67CEQ33628037-45C85DAD-BC83-4F82-8D52-DDD8D0908AD0Q33628869-38B82D43-45F8-444A-9FD9-C8A983A69F02Q33631223-7A08CB8A-48C2-4930-AFF5-F706BEBF2DB8Q33699222-6D613592-4E8E-487F-AC08-014AC60223DBQ33727225-0A830F44-2011-4BD5-A5EC-CEB1A265A399Q33757601-0FDA7F01-66B1-49E1-BA59-CC3229BBBD6CQ33799373-459E90F9-6DCB-4217-AA02-EFEEABC3AD11Q33827518-39B6DBA1-38B3-40C3-AE0A-3A00831095CA
P2860
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
The AIDS dementia complex: I. Clinical features.
@en
The AIDS dementia complex: I. Clinical features.
@nl
type
label
The AIDS dementia complex: I. Clinical features.
@en
The AIDS dementia complex: I. Clinical features.
@nl
prefLabel
The AIDS dementia complex: I. Clinical features.
@en
The AIDS dementia complex: I. Clinical features.
@nl
P2093
P356
P1433
P1476
The AIDS dementia complex: I. Clinical features.
@en
P2093
P304
P356
10.1002/ANA.410190602
P577
1986-06-01T00:00:00Z